Jw Pharmaceutical Corporation logo

Jw Pharmaceutical Corporation (001060)

Market Closed
12 Jun, 05:41
KRX SM KRX SM
23,950. 00
+250
+1.05%
538.37B Market Cap
- P/E Ratio
1,600% Div Yield
113,229 Volume
- Eps
23,700
Previous Close
Day Range
23,450 24,250
Year Range
19,600 34,950
Earnings results expected in 48 days

Summary

001060 closed today higher at ₩23,950, an increase of 1.05% from yesterday's close, completing a monthly increase of 2.79% or ₩650. Over the past 12 months, 001060 stock lost -0.62%.
001060 is not paying dividends to its shareholders.
The last earnings report, released on May 06, 2025, exceeded the consensus estimates by 675.23%. On average, the company has surpassed earnings expectations by 225.08%, based on the last three reports. The next scheduled earnings report is due on Jul 30, 2025.
Jw Pharmaceutical Corporation has completed 5 stock splits, with the recent split occurring on Dec 27, 2023.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).
Want to track 001060 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

001060 Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.

Jw Pharmaceutical Corporation Dividends

Jw Pharmaceutical Corporation logo
001060 5 months ago
Other
₩450 Per Share
Jw Pharmaceutical Corporation logo
001060 27 Dec 2023
Other
₩400 Per Share
Jw Pharmaceutical Corporation logo
001060 28 Dec 2022
Other
₩356.94 Per Share
Jw Pharmaceutical Corporation logo
001060 29 Dec 2021
Other
₩309.35 Per Share
Jw Pharmaceutical Corporation logo
001060 29 Dec 2020
Other
₩291.59 Per Share

Jw Pharmaceutical Corporation Earnings

30 Jul 2025 (48 Days) Date
-
Cons. EPS
-
EPS
6 May 2025 Date
-
Cons. EPS
675.23
EPS
3 Feb 2025 Date
-
Cons. EPS
-
EPS
6 Nov 2024 Date
-
Cons. EPS
-
EPS
7 Aug 2024 Date
527.05
Cons. EPS
-
EPS
Jw Pharmaceutical Corporation logo
001060 5 months ago
Other
₩450 Per Share
Jw Pharmaceutical Corporation logo
001060 27 Dec 2023
Other
₩400 Per Share
Jw Pharmaceutical Corporation logo
001060 28 Dec 2022
Other
₩356.94 Per Share
Jw Pharmaceutical Corporation logo
001060 29 Dec 2021
Other
₩309.35 Per Share
Jw Pharmaceutical Corporation logo
001060 29 Dec 2020
Other
₩291.59 Per Share
30 Jul 2025 (48 Days) Date
-
Cons. EPS
-
EPS
6 May 2025 Date
-
Cons. EPS
675.23
EPS
3 Feb 2025 Date
-
Cons. EPS
-
EPS
6 Nov 2024 Date
-
Cons. EPS
-
EPS
7 Aug 2024 Date
527.05
Cons. EPS
-
EPS

Jw Pharmaceutical Corporation (001060) FAQ

What is the stock price today?

The current price is ₩23,950.00.

On which exchange is it traded?

Jw Pharmaceutical Corporation is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 001060.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 538.37B.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 30, 2025.

Has Jw Pharmaceutical Corporation ever had a stock split?

Jw Pharmaceutical Corporation had 5 splits and the recent split was on Dec 27, 2023.

Jw Pharmaceutical Corporation Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Young-Sub Shin CEO
KRX SM Exchange
KR7001060003 ISIN
KR Country
1,048 Employees
- Last Dividend
27 Dec 2023 Last Split
- IPO Date

Overview

JW Pharmaceutical Corporation operates both within Japan and internationally, engaging in the manufacturing and distribution of medicines and medical supplies. Since its inception in 1945, the company has grown to become a vital player in the healthcare industry, providing a wide range of products aimed at improving the health and well-being of its customers. Based in Gwacheon-si, South Korea, JW Pharmaceutical Corporation has dedicated itself to addressing various medical needs, spanning from critical areas such as cancer and immunological diseases to general health and beauty care.

Products and Services

  • Cancer, Immunological Disease, Cardiovascular System and Metabolic Diseases, Regenerative Medicine, Eye Diseases, and Pancreatic Cancer Products

    The core of JW Pharmaceutical Corporation's product line focuses on the development and distribution of treatments for major health concerns, including cancer, immunological diseases, cardiovascular and metabolic diseases, regenerative medicine, eye diseases, and specifically pancreatic cancer. Through intensive research and development, the company strives to bring innovative medicines to the market, hoping to improve patient outcomes in these critical areas.

  • Infant Care System, Gynecological Examining Table, Operating Room Equipment, Steam Sterilizer

    Beyond pharmaceuticals, JW Pharmaceutical Corporation offers a range of medical equipment designed to support healthcare professionals. This includes infant care systems for the youngest patients, gynecological examining tables for women's health, a variety of operating room equipment for surgical needs, and steam sterilizers for ensuring the sterility of medical tools and environments.

  • Wound Care, Pain Care, and Beauty Care Related Products

    Addressing the everyday health and wellness needs of individuals, JW Pharmaceutical Corporation has also developed products focusing on wound care, pain management, and beauty care. These products aim to enhance the quality of life for their users by providing relief and support for common health and aesthetic concerns.

Contact Information

Address: JW Gwacheon Tower, 38, Gwacheon-si, South Korea, 13840
Phone: 82 2 8406 777